|Year : 2018 | Volume
| Issue : 2 | Page : 150-157
Clinical and histological evaluation on application of platelet concentrates on depigmented gingival epithelium
Koel Debnath, Anirban Chatterjee
Department of Periodontology, The Oxford Dental College, Bengaluru, Karnataka, India
|Date of Submission||10-Dec-2017|
|Date of Acceptance||09-Feb-2018|
|Date of Web Publication||23-Apr-2018|
Dr. Koel Debnath
#106, Block- B, GK Jewel City Apartment, Kudlu Harlur, Main Road, Kudlu, Bengaluru - 560 068, Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: The platelet concentrate is a windfall in the field of regenerative therapy in periodontology. It accelerates wound healing by excellent neovascularization and promoting fast cicatricle tissue remodeling. Aim: This study aims to evaluate clinically and histologically accelerated effect of platelet-rich fibrin (PRF) membrane and PRF matrix (PRFM) following depigmentation procedure. Materials and Methods: Eleven individuals were divided into three groups after depigmentation procedure. PRF membrane and PRFM gel were prepared as per standard protocol. Group A and B received PRF membrane and PRFM gel followed by periodontal dressing, respectively, and the only periodontal dressing was placed in Group C. The individuals were evaluated for visual analog scale (VAS) and healing index (HI) on 3rd and 5th day. Epithelization test and histologic analysis from punch biopsy were done on the 5th day. At 3rd month, reevaluation was performed. Results: The intergroup statistical analysis in respect to VAS, HI, epithelization test, and histologic analysis showed a statistically significant results with P < 0.001 in Groups A and B compared to Group C. Clinical evaluation of epithelization test and histologic analysis revealed better-wound healing and moderate to no inflammatory cell infiltrate in Groups A and B, respectively, as compared to Group C, which appeared more erythematous with dense inflammatory cells. Conclusion: Thus, the application of PRF membrane and PRFM gel has shown a successful approach to protect the raw wound area of depigmented sites with better patient comfort and faster healing.
Keywords: Depigmentation, platelet-rich fibrin, platelet-rich fibrin matrix
|How to cite this article:|
Debnath K, Chatterjee A. Clinical and histological evaluation on application of platelet concentrates on depigmented gingival epithelium. J Indian Soc Periodontol 2018;22:150-7
|How to cite this URL:|
Debnath K, Chatterjee A. Clinical and histological evaluation on application of platelet concentrates on depigmented gingival epithelium. J Indian Soc Periodontol [serial online] 2018 [cited 2020 Feb 23];22:150-7. Available from: http://www.jisponline.com/text.asp?2018/22/2/150/230838
| Introduction|| |
In today's era, facial cosmetic concerns, as well as increased intraoral awareness, have created a demand for esthetics in the periodontal practice. The gingiva is considered to be the most frequently pigmented region of the oral cavity. The color variation in the gingiva mainly depends on the thickness of the gingival epithelium, blood supply, amount of the keratinization, and number of the pigmented cells present. Melanin, a nonhemoglobin endogenous-derived pigment, is responsible for normal pigmentation of the skin, gingiva, and remainder of the oral mucous membrane. The pigmentation appears as a diffuse purplish discoloration or light-brown patches which were irregularly arranged. Clinically, it is manifested as multifocal or diffuse melanin pigmentation. The distribution of the pigmentation is variable with different ethnic groups worldwide and is prevalent in all races., The physiologic melanin deposition takes place by melanocytes present between basal and suprabasal cell layers of epithelium. The melanin pigmentation was mostly seen at a higher degree in the anterior region., The size and degree of melanin pigmentation are directly proportional to the degree of melanin pigmentation. The brown or dark pigmentation or discoloration could be considered due to various multifactorial etiology and also due to genetic factors.,,,,,
Clinical melanin pigmentation is benign and is not a medical problem, but pigmented gingiva may be a cause of an esthetic concern particularly, especially during speech and smile. The demand for the cosmetic surgery was especially more seen in the fair-skinned individual with high smile line. Gingival depigmentation can be performed by various techniques including scalpel, bur, laser, and chemicals whereby the gingival hyperpigmentation is removed or reduced. The procedure aims in the removal of gingival epithelium along with a layer of the underlying connective tissue and allowing the denuded connective tissue to heal by secondary intention. Coverage of exposed connective tissue minimizes the likelihood of postoperative bleeding and facilitates healing by preventing surface trauma. The use of platelet concentrates known for its immense reparative potential  could be a boon for rapid epithelization on the depigmented gingival surface.
Thus, the present research aimed to evaluate clinically and histologically the effect of platelet concentrates (platelet-rich fibrin [PRF] membrane and PRF matrix [PRFM] gel) after depigmentation.
| Materials and Methods|| |
The nonrandomized split-mouth interventional study was conducted in Bengaluru, India. 11 healthy controls were recruited who had an esthetic concern due to gingival hyperpigmentation and demanded a need for depigmentation procedure. Ethical clearance was obtained from the local ethical committee of the institution.
The inclusion criteria included systemically healthy controls with an age range of 20–30 years. The individuals presented moderate clinical pigmentation which appeared to be medium brown or mixed pink and brown color as seen in [Figure 1]. The plaque index score of <1 and gingival index score <1, thick biotype, >2 mm of attached gingiva, and absence of endodontically involved teeth. The exclusion criteria included the presence of gingival recession, thin gingival biotype, individuals on antibiotic or anti-inflammatory drugs for past 3 months, underwent periodontal surgery in past 6 months, individuals with a habit of smoking/tobacco chewing and pregnant and lactating mothers.
On fulfilling the inclusion as mentioned above and exclusion criteria, the individuals were informed about the surgical procedure along with the application of platelet concentrates and the benefit that can be obtained from it. A signed informed consent was obtained from all the 11 individuals.
The individuals were divided into 3 groups based on the application of platelet concentrates after the depigmentation procedure.
The depigmentation procedure was carried out by abrasion technique as observed in [Figure 2]. Following the depigmentation procedure, the groups were divided in the following way as noted in [Figure 3]:
- Group A: Right maxillary quadrant received the PRF membrane
- Group B: Left maxillary quadrant received the PRFM gel
- Group C: The mandibular anterior sextant received only the periodontal pack placement.
The individuals were refrained from brushing for 3 days following the procedure and were instructed to rinse mouth with 0.2% chlorhexidine Digluconate mouthwash. On the 3rd day, the individuals were recalled, and the periodontal pack was removed.
The clinical and histological parameters were evaluated following the surgical procedure. The visual analog scale (VAS) and healing index (HI) were evaluated at 3rd and 5th day  and epithelialization test at 5th day. The histological analysis was carried out on the 5th day through punch biopsy from the depigmented gingival epithelium.
Preparation of platelet concentrates
10 ml of blood samples was collected from individuals participating in the clinical trial. The samples were further processed for preparation of PRF membrane and PRFM gel as per the conventional centrifugation protocol.
Preparation of platelet-rich fibrin membrane
5 ml of blood present in glass vacutainer was centrifuged in REMI4 (*R-4C, REMI Laboratory Instruments, Mumbai, India) centrifugation machine for 2800 rpm for 12 min. The gel obtained following the centrifugation had three layers. The top layer being platelet poor plasma and bottom layer consisted of concentrated red blood cells. The middle layer harboured fibrin network gel as observed in [Figure 4].
|Figure 4: Preparation of platelet-rich fibrin membrane (a) Blood withdrawn from antecubital vein; (b) centrifuged at 2700 rpm for 12 minutes; (c) the Platelet rich fibrin (PRF) obtained; (d) PRF gel was squeezed between sterile gauze to form Platelet rich fibrin membrane|
Click here to view
The gel was then compressed in between sterile gauze pieces, and the supernatant was discarded to obtain the PRF membrane.
Preparation of platelet-rich fibrin matrix
Five milliliter of blood was transferred to Meresis PRFM kit (Meresis, laboratory, Bangalore, India) using a single spin centrifugation method. It was centrifuged at rpm of 3000 for 10 min. The supernatant obtained at the top of gel was removed through syringe, and activator containing 0.1% gluconate was added and mixed for 9–10 times to achieve the PRFM gel as seen in [Figure 5].
|Figure 5: Preparation of platelet-rich fibrin matrix (a) blood was withdrawn fromantecubital vein; (b) transferred to Meresis PRFM kit; (c) centrifuged at rpm of 3000 for 10 min; (d) The supernatant obtained at the top of gel was removed through syringe; (e) activator containing 0.1% gluconate was added and mixed for 9–10 times; (f) PRFM gel was obtained|
Click here to view
The depigmentation procedure was carried out by abrasion technique with the use of a medium grit football-shaped diamond bur with feather-like brushing strokes under copious water lavage. The individuals underwent depigmentation procedure with abrasion technique in maxillary right and left and mandibular anterior teeth region. On the maxillary upper quadrant, PRF membrane was placed as contemplated in [Figure 6]. The membrane was stabilized with 5- 0 absorbable suture followed by periodontal pack placement. On left maxillary quadrant, PRFM gel was uniformly spread over the depigmented epithelium as observed in [Figure 7] and was covered with the periodontal pack. The mandibular anterior sextant directly received periodontal pack following depigmentation procedure as seen in [Figure 8]. The postoperative view at 3rd and 5th day was contemplated in [Figure 9] and [Figure 10].
|Figure 6: Application of platelet-rich fibrin membrane on the first quadrant following depigmentation (a) The de-epitheliliazed 1st quadrant;(b) platelet rich fibrin (PRF) membrane placed; (c) periodontal pack placed|
Click here to view
|Figure 7: Application of platelet-rich fibrin matrix on second quadrant following depigmentation (a) The de-epitheliliazed 2nd quadrant site; (b) platelet rich fibrin matrix gel (PRFM) placed; (c) periodontal pack placed|
Click here to view
|Figure 8: Application of periodontal pack on lower anterior teeth region following depigmentation (a) The de- epithelialized site in mandibular anterior site; (b) periodontal pack was placed|
Click here to view
|Figure 9: Post operative view at 3rd day (a) The 1st, 2nd quadrant; (b) mandibular anterior teeth region lower anterior teeth region|
Click here to view
The results were statistically evaluated using SPSS Inc., (Released 2009 PASW Statistics for Windows, Version 18.0. Chicago). The power of the study was 90%, and a P < 0.05 was considered statistically significant. The intergroup comparison of the clinical parameters was evaluated with Fischer's extract test.
| Results|| |
The application of platelet concentrates on the maxillary right and left quadrant has shown promising results concerning the clinical parameters as compared to Group C which received periodontal pack placement [Figure 11].
|Figure 11: (a) Pre-operative view and (b) Post operative at 3rd month interval|
Click here to view
Visual analog scale
The VAS in the individuals at 3rd day showed 5 individuals receiving platelet concentrate had moderate pain with 45.5% whereas 9 individuals with 81.09% in periodontal pack placement in mandibular anterior teeth region have demonstrated severe pain. Statistically, the percentage evaluation in Group A and B was statistically significant as compared to Group C with the P < 0.001.
On the 5th day, all the 11 individuals with 100% VAS score did not have pain in the platelet concentrate depigmented area whereas 11 individuals in Group C had moderate pain which when evaluated statistically showed significant results for Group A and B as compared to Group C with the P < 0.001. The same observation is tabulated in [Table 1] and [Figure 12].
|Table 1: Percentage of healing index score obtained in Groups A, B, and C on 3rd and 5th day postsurgery|
Click here to view
|Figure 12: Percentage of visual analog scale (VAS)perceived by individuals at 3rd and 5th day in Platelet rich fibrin (PRF), Platelet rich fibrin matrix (PRFM) and Periodontal pack (PACK) groups|
Click here to view
The various scores present in the healing index as per Landry et al. 19 have shown that on the 3rd day following depigmentation, all the individuals had good healing in Groups A and B as compared to Group C where 7 individuals with 63.6% had the poor healing score and 4 individuals had good healing. Statistical tabulation observed a statistically significant difference with the P < 0.001 in Groups A and B as compared to Group C as observed in [Figure 13].
|Figure 13: Percentage of healing observed in Groups A, B, and C on 3rd and 5th day as per healing index in Platelet rich fibrin (PRF), Platelet rich fibrin matrix (PRFM) and Periodontal pack( PACK) groups|
Click here to view
On the 5th day, all the 11 individuals in the Group C had shown good healing, and the sites that received platelet concentrates had a very good healing score. The same has been observed in [Table 2] and [Figure 13].
|Table 2: Percentage of visual analog scale rating sore obtained on 3rd and 5th day in Groups A, B, and C|
Click here to view
On the 5th day, the maxillary right and left quadrant and mandibular anterior sextant was substantially stained with toluidine blue. 10 individuals with 90.90% in the Group B (PRFM gel) quadrant and 6 individuals 54.50% in Group A had taken the mild staining which was statistically significant with P < 0.001 as compared to mandibular anterior sextant of Group C where 5 individuals had severe stain uptake with 45.5%. It denoted the presence of less inflammatory cells in the platelet concentrates group as compared to periodontal pack group with uneventful healing. The toluidine blue uptake was seen in [Figure 14]. The statistical tabulation is observed in [Table 3] and [Figure 15].
|Table 3: Percentage of epithelialization test score obtained on 5th day for Groups A, B, and C|
Click here to view
|Figure 15: Percentage of epithelialization observed at 5th day with toluidine blue in Platelet rich fibrin (PRF), Platelet rich fibrin matrix (PRFM) and Periodontal pack (PACK) groups.|
Click here to view
At 5th day after the surgical procedure, a section of tissue from the lateral incisor region in maxillary arch and mandibular arch was taken through punch biopsy from all the treated sites. Hematoxylin and eosin stained slides was prepared from all the tissues. At ×40 magnification, the inflammatory cell infiltrates was observed in [Figure 16]. The 7 individuals in Group B, i.e., PRFM group had shown a distinct parakeratinized stratified squamous epithelium with fibrous connective tissue with nil inflammatory cell infiltrates and 8 individuals in Group A, i.e., PRF group had demonstrated moderate inflammatory cell infiltrate with 70% and 9 individuals in Group C had severe inflammatory cell infiltrate with 81.8%. Statistically, when tabulated, Group B was statistically significant as compared to Groups A and C. These data can be contemplated in [Table 4] and [Figure 17].
|Figure 16: Histological analysis at 5th day with toluidine blue in Platelet rich fibrin (PRF), Platelet rich fibrin matrix (PRFM) and Periodontal pack (PACK) groups|
Click here to view
|Table 4: Percentage of histological analysis for the presence of inflammatory cells on 5th day in Groups A, B, and C|
Click here to view
|Figure 17: Presence of inflammatory cell infiltrate through histological analysis at 5th day in Platelet rich fibrin (PRF), Platelet rich fibrin matrix (PRFM), Periodontal pack (PACK) groups|
Click here to view
| Discussion|| |
The hyperpigmentation of the gingiva is an esthetic concern for the individual; though not a medical condition, it requires the removal of the hyperpigmented gingival epithelium. The depigmentation leaves behind an exposed connective tissue on the gingival surface for the healing to take place by secondary intention. An attempt to cover the surgical site with platelet concentrates has been evaluated. The results obtained from the study using the platelet concentrates could be elaborated due to the immense potential of the biomaterial in terms of VAS, HI, epithelialization test, and histological analysis as compared to periodontal pack.
The 2nd generation PRF has been utilized and investigated in various forms in the field of periodontology. A measurable result was obtained when used in the treatment of intrabony defects, gingival recession, and furcation defects. The PRF membrane has been used as palatal bandage following free gingival graft procedure where satisfactory patient comfort was achieved. The distinguishable results from various treatment modalities could be attributed to its fibrin structure and the release of various growth factors for a prolong period. The PRF blood clot contains >97% of platelets that was sufficient to accelerate soft- and hard-tissue healing. The fibrin matrix being in a tetramolecular structure incorporates platelets, leukocytes, cytokines, and circulating stem cells.
The fibrin matrix also contains glycol aminoglycans which have a strong affinity for circulating peptides and can support cell migration and healing process. PRF is the activated form of a plasmatic molecule called fibrinogen. The fibrin formed after the centrifugation is transformed into a kind of biologic glue which consolidates the initial platelet cluster, thus constituting a protective wall along vascular breaches during coagulation. The fibrin architecture entraps various numbers of leukocytes in the fibrin matrix allowing intense slow release of growth factors. It favors the sealing of wound borders and allows an uneventful proliferative phase by the steady release of growth factors such as platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF), fibroblast growth factor (FGF), insulin growth factor (IGF), and transforming growth factor (TGF) which are known to play pivotal role in wound healing process.,,,,
The first-generation platelet concentrate introduced by Marx et al., in 1998 is known to act on healing inducible cells to increase their numbers through mitogenesis and perform angiogenesis by stimulating vascular ingrowth. The PRF matrix PRFM gel used in the study was a first-generation platelet concentrate in which addition of calcium gluconate as an activator was known to enhance the release of various growth factors in a more substantial quantity for a shorter period. Kobayashi et al., in 2016 evaluated the growth factor release from PRF, PRP, and APRF advanced platelet rich fibrin for 10 days which showed a robust release of PRP for a shorter period as compared to other platelet concentrates.
In the present study, a statistical significant difference was observed in HI, epithelialization test and VAS score in the test groups i.e. Group A (PRF) and Group B (PRFM) as compared to Group C (Periodontal pack). The result could be attributed to the release of PDGF, VEGF, EGF, FGF, IGF, and from both the platelet concentrates.
The histological analysis done at 5th day has observed a statistically significant difference in PRFM group as compared to PRF and periodontal pack group. The reason behind the absence of inflammatory cell infiltrates in Group B was due to its robust and rapid release of growth factors for a shorter period of time. Studies done by Gassling et al., in 2009 and Lucarelli et al. in 2010 has evaluated the release of PDGF, EGF, TGF1, EGF, and FGF for 10 days and observed a maximum release of growth factors were seen on the 1st day of PRP group and a constant release of growth factors was seen in PRF group suggesting a rapid release of growth factors from first-generation platelet concentrates in the initial stage of healing period which enhanced the wound healing process. Carroll et al. in 2005 evaluated the PRFM group for 10 days and observed 5 times more platelet entrapment in the fibrin mesh leading to a faster and increased concentration of growth factors (PDGF, VEGF, and EGF).
Severe inflammatory infiltrates remained in Group C as the periodontal pack does not have any curative properties and is a dimensionally unstable material which shows contraction during the first minutes after completion of their setting, resulting in delayed healing.,
The present study is in accordance with the only study conducted by Bansal et al. in 2016 where PRF membrane along with periodontal pack was placed after depigmentation procedure in 5 individuals. However, the present study had compared two platelet concentrates, i.e., PRF and PRFM and had recruited a larger sample size comprising of 11 individuals. All the results were clinically and statistically tabulated. The use of platelet concentrates is necessary to cover the exposed lamina propria as healing occurs with secondary intention, which is delayed if the surgical site is left exposed. The connective tissue repair would establish and maintain the adherence of fibrin clot which is a natural phenomenon of wound healing process. Thus, with the addition of platelet concentrates, a better patient comfort and rapid wound healing was viewed. As per our thorough literature research, the present research is the first of its own kind where the application of PRFM gel along with PRF membrane has been evaluated in gingival epithelialization and yielded an enhanced response in wound healing process.
| Conclusion|| |
Thus, the application of PRF membrane and PRFM gel in the present study has shown a successful approach to protect the raw wound area of depigmented sites with a better patient comfort and faster healing than the use of periodontal pack alone.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Newman MG, Takei HH, Klokkevold PR, Carranza FA. Carranza's Clinical Periodontology. 11th
ed. St. Louis, MO: Elsevier/Saunders; c2012. p. 1938.
Dummett CO. Oral pigmentation:First symposium of oral pigmentation. J Periodontol 1960;31:356.
Dummett CO, Barens G. Pigmentation of the oral tissues: A review of the literature. J Periodontol 1967;38:369-78.
Ciçek Y, Ertaş U. The normal and pathological pigmentation of oral mucous membrane: A review. J Contemp Dent Pract 2003;4:76-86.
Dummett CO. Overview of normal oral pigmentations. J Indiana Dent Assoc 1980;59:13-8.
Hedin CA, Larsson A. The ultrastructure of the gingival epithelium in smokers' melanosis. J Periodontal Res 1984;19:177-90.
Regezi JA, Sciubba J. Oral Pathology, Clinical Pathologic Correlations. Philadelphia: W. B. Saunders Co.; 1993. p. 161.
Shafer WG, Hine MK, Levy BM. A Textbook of Oral Pathology. Philadelphia: W.B. Saunders Co.; 1984. p. 89-136.
Granstein RD, Sober AJ. Drug-and heavy metal – Induced hyperpigmentation. J Am Acad Dermatol 1981;5:1-8.
Savage NW, Barber MT, Adkins KF. Pigmentary changes in rat oral mucosa following antimalarial therapy. J Oral Pathol 1986;15:468-71.
Dummett CO. A classification of oral pigmentation. Mil Med 1962;127:839-40.
Ginwalla TM, Gomes BC, Varma BR. Surgical removal of gingival pigmentation. (A preliminary study). J Indian Dent Assoc 1966;38:147.
Suchetha A, Lakshmi P, Bhat D, Mundinamane DB, Soorya KV, Bharwani GA, et al.
Platelet concentration in platelet concentrates and periodontal regeneration-unscrambling the ambiguity. Contemp Clin Dent 2015;6:510-6.
] [Full text]
Dummett CO, Gupta OP. Estimating the epidemiology of oral pigmentation. J Natl Med Assoc 1964;56:419-20.
Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-51.
Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand 1964;22:121-35.
Putter OH, Ouellet D, Putter A, Vilaboa D, Vilaboa B, Fernandez M. A non-traumatic technique for removing melanotic pigmentation lesions from the gingiva: Gingival abrasion. Dent Today 1994;13:58-60.
Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 1990;13:227-36.
Landry RG, Turnbull RS, Howley T. Effectiveness of benzydamine HCL in the treatment of periodontal post-surgical patients. Res Clin Forums 1988;10:105-18.
Sridharan G, Shankar AA. Toluidine blue: A review of its chemistry and clinical utility. J Oral Maxillofac Pathol 2012;16:251-5. [Full text]
Gassling VL, Açil Y, Springer IN, Hubert N, Wiltfang J. Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:48-55.
Simon BI, Zatcoff AL, Kong JW, S.M O connell. Clinical and histological comparison of extraction socket healing following the use of autologous platelet-rich fibrin matrix (PRFM) to ridge preservation procedures employing demineralized freeze dried bone allograft material and membrane. Open Dent J 2009;3:92-9.
Lin YH, Tu YK, Lu CT, Chung WC, Huang CF, Huang MS, et al.
Systematic review of treatment modalities for gingival depigmentation: A random-effects poisson regression analysis. J Esthet Restor Dent 2014;26:162-78.
Pradeep AR, Rao NS, Agarwal E, Bajaj P, Kumari M, Naik SB, et al.
Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of 3-wall intrabony defects in chronic periodontitis: A Randomized Controlled Clinical Trial. J Periodontol 2012;83:1499-507.
Aleksić Z, Janković S, Dimitrijević B, Divnić-Resnik T, Milinković I, Leković V, et al.
The use of platelet-rich fibrin membrane in gingival recession treatment. Srp Arh Celok Lek 2010;138:11-8.
Bajaj P, Pradeep AR, Agarwal E, Rao NS, Naik SB, Priyanka N, et al.
Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: A randomized controlled clinical trial. J Periodontal Res 2013;48:573-81.
Aravindaksha SP, Batra P, Sood V, Kumar A, Gupta G. Use of platelet rich fibrin (PRF) membrane as palatal bandage. Clin Adv Periodontics 2013;4:1-6.
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al.
Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e45-50.
Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barbé G, Del Corso M, Inchingolo F, et al.
Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 2012;13:1145-52.
van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N
Y Acad Sci 2001;936:426-37.
Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, et al.
Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clin Oral Investig 2016;20:2353-60.
Lucarelli E, Beretta R, Dozza B, Tazzari PL, O'Connel SM, Ricci F, et al.
Arecently developed bifacial platelet-rich fibrin matrix. Eur Cell Mater 2010;20:13-23.
Carroll RJ, Amoczky SP, Graham S, O'Connell SM. Characterization of Autologous Growth Factors in Cascade Platelet Rich Fibrin Matrix (PRFM). Edison, NJ: Musculoskelatal Transplant Foundation; 2005.
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-46.
Sachs HA, Farnoush A, Checchi L, Joseph CE. Current status of periodontal dressings. J Periodontol 1984;55:689-96.
Kathariya R, Jain H, Jadhav T. To pack or not to pack: The current status of periodontal dressings. J Appl Biomater Funct Mater 2015;13:e73-86.
Bansal M, Kumar A, Puri K, Khatri M, Gupta G, Vij H, et al.
Clinical and histologic evaluation of platelet-rich fibrin accelerated epithelization of gingival wound. J Cutan Aesthet Surg 2016;9:196-200.
] [Full text]
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9], [Figure 10], [Figure 11], [Figure 12], [Figure 13], [Figure 14], [Figure 15], [Figure 16], [Figure 17]
[Table 1], [Table 2], [Table 3], [Table 4]